drugset / Trial / NCT01645748
Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Head and Neck Cancer
Phase 2
Completed
35 enrolled
Chonnam National University Hospital
Chonbuk National University · collabChungbuk National University · collabChungnam National University · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study was to evaluate the tolerability and efficacy of a combination of weekly docetaxel, cisplatin, and S-1 (weekly TPS) as induction chemotherapy in patients with locally advanced head and neck squamous cell carcinoma (HNSCC).
Timeline
- Start
- 2008-10
- Primary completion
- 2011-10
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 60 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 30 mg/m2 | — |
| Subject | S-1 | Small molecule | 70 mg/m2 | Oral |